Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Choose from credit cards with zero annual fees that offer cash back rewards. Keep all your rewards and maximize your savings.
23,592 articlesInvestors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
As data needs soar, memory makers like Micron Technology face a pivotal five-year horizon. This guide breaks down the...
Bitcoin could mount a major rally as a liquidity wave from Washington enters the system. A market note outlines two p...
Markets opened with caution, nudging major indexes lower as investors weighed earnings and inflation data. This guide...
A bold claim from a top energy chief has investors reassessing risk. This guide breaks down what a tight oil market c...
A large fund sold a sizable stake, and the stock still lagged the market. This look breaks down what happened, why it...
Occidental Petroleum is leading oil peers in early 2026, with a solid YTD run that outpaces ConocoPhillips and Diamon...
In today’s market briefing, Opendoor climbs as it nears a Russell 3000 inclusion, while broader indices tread water. ...
Orion (OESX) 2026 earnings reveal a company navigating growth opportunities and profitability challenges. This deep d...
As UNFI approaches its 2026 earnings call, investors want clarity on margins, growth drivers, and capital strategy. T...
Two stalwarts of the insurance world compete for a spot in a 2026 portfolio. This article breaks down Lincoln Nationa...
A sharp intraday move put Poet Technologies in the spotlight, but a single day doesn’t tell the full story. This guid...